Diagnostic value of piezogenic papules in childhood: A scoping review and analysis of existing data
Abstract
Introduction: Piezogenic papules (PP) are soft, skin-colored or yellowish herniations of subcutaneous fat appearing under pressure, commonly on the heels. While usually benign, they may cause pain and have been associated with Ehlers-Danlos syndrome. PP are included in the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome (hEDS), and in the 2023 framework for pediatric joint hypermobility, but their prevalence in healthy children and their clinical threshold remain unclear.
Aim: To map current knowledge on the prevalence of PP in healthy children and adolescents and to analyze previously collected clinical data from healthy adolescents and those with Hypermobility Spectrum Disorder (HSD) or hEDS.
Methods: A scoping review was conducted. Peer-reviewed studies reporting PP prevalence or clinical characteristics in healthy children and adolescents (0-17 years) or including healthy controls were included. Additionally, clinical data from adolescents assessed for hEDS (2017 criteria) and healthy controls were analyzed descriptively.
Results: Of 707 identified articles, four observational studies and five case reports met the inclusion criteria. Across the reviewed studies, PP prevalence in children ranged from 16 to 72%, was generally asymptomatic. In the empirical cohort, PP were observed in 76% of individuals with HSD/hEDS and 60% in the control group, corresponding to a prevalence difference of 16% points (95% CI - 4 to 36; p = 0.163).
Conclusion: PP are common…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.